The polymer–agonist combination was applied to subcutaneous tumour-bearing mice and resected human tumours and lymph nodes, and showed that PC7A induces a more prolonged formation of pro-inflammatory cytokines compared to the natural STING ligand by binding to a non-competitive STING surface. Here, STING1 is linked to neoplasm.